Capital formation financing options evaluation
Company: Core Scientific
The claim, verbatim
Company is evaluating a number of financing options to support broader capital formation strategy
Source (primary)
core-scientific 8-K exhibit (q4fy25earningsdeckvfinal.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-13)Live source ↗
Quote: “Evaluating a number of financing options to support our broader capital formation strategy”
How we checked this
Checked on September 21, 2026. The cited source supports every part of this claim.
The document's slide on advancing commitments states the company is evaluating a number of financing options to support its broader capital formation strategy.
Confirmed in the source:
- Core Scientific is evaluating a number of financing options to support its broader capital formation strategy
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/q4fy25earningsdeckvfinal.htm) in full (14,391 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (q4fy25earningsdeckvfinal.htm)
Quote: “Evaluating a number of financing options to support our broader capital formation strategy”